Symbols

CELZ

Creative Medical·NASDAQ

--(--)

Signals Analysis

Bullish signal 3

Bearish signal 1

Stock Price Surged Significantly

Ample Liquidity

High Gross Profit Margin

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About CELZ

Creative Medical Technology Holdings, Inc.

A commercial-stage biotech company that focuses on treating erectile dysfunction and stroke

Industry

Biological Technology

Established Date

12/03/1998

Listing Date

12/03/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.creativemedicaltechnology.com

Security Type

Common stock

Office address

211 E Osborn Road, Phoenix, AZ 85012

Business

Introduction

Creative Medical Technology Holdings, Inc., was incorporated in Nevada on December 3, 1998. The company is a commercial-stage biotechnology company dedicated to advancing regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics.

Company Financials

EPS

CELZ has released its 2025 Q3 earnings. EPS was reported at -0.48, versus the expected -0.41, missing expectations. The chart below visualizes how CELZ has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

CELZ has released its 2025 Q4 earnings report, with revenue of 3.00K, reflecting a YoY change of 0.00%, and net profit of -1.89M, showing a YoY change of -1.81%. The Sankey diagram below clearly presents CELZ's revenue sources and cost distribution.